Dan Sheng
Director/Board Member presso BEIJING STRONG BIOTECHNOLOGIES,INC.
Patrimonio netto: 947 146 $ in data 31/03/2024
Profilo
Dan Sheng has held multiple positions throughout her career.
Currently, she is the Director & Executive Deputy General Manager at Beijing Strong Biotechnologies, Inc. since 2016.
She is also a Member-Supervisory Board at Fuzhou Maixin Biotech Co., Ltd.
since 2020.
In terms of education, Dr. Sheng holds an MBA from The University of Chicago, which she obtained in 2012.
She also has a doctorate degree from New York University, conferred in 2004.
Additionally, she completed her undergraduate studies at the University of Science & Technology of China in 2000.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/05/2023 | 354 687 ( 0.11% ) | 947 146 $ | 31/03/2024 |
Posizioni attive di Dan Sheng
| Società | Posizione | Inizio |
|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Board Member | 13/08/2020 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 30/09/2020 |
Formazione di Dan Sheng
| The University of Chicago | Masters Business Admin |
| New York University | Doctorate Degree |
| University of Science & Technology of China | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Borsa valori
- Insiders
- Dan Sheng
